0001127602-15-021101.txt : 20150622
0001127602-15-021101.hdr.sgml : 20150622
20150622064702
ACCESSION NUMBER: 0001127602-15-021101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150618
FILED AS OF DATE: 20150622
DATE AS OF CHANGE: 20150622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULLIVAN LOUIS W
CENTRAL INDEX KEY: 0001193522
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 15943664
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN LOUIS
DATE OF NAME CHANGE: 20020927
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-06-18
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001193522
SULLIVAN LOUIS W
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
Common Stock
2015-06-18
4
M
0
30000
41.14
A
30000
D
Common Stock
2015-06-18
4
D
0
30000
185.78
D
0
D
Common Stock
2015-06-18
4
M
0
15000
30.75
A
15000
D
Common Stock
2015-06-18
4
S
0
15000
185.5982
D
0
D
Share Tracking Award
41.14
2015-06-18
4
M
0
30000
0
D
2010-06-26
2019-06-26
Common Stock
30000
0
D
Stock Options
30.75
2015-06-18
4
M
0
15000
0
D
2009-04-29
2018-04-29
Common Stock
15000
15000
D
Exercise of a cash-settled share tracking award.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $185.25 to $186.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2015-06-22